Sep 27
NEW YORK — Regulators are putting their harshest warning on Pfizer’s antibiotic Tygacil, saying the drug is associated with an increased risk of death.
The Food and Drug Administration said Friday Tygacil, or tigecycline, should only be used in situations when other treatments aren’t suitable. The intravenous drug is approved as a treatment for complicated skin and skin structure infections and community-acquired bacterial pneumonia. The FDA will add a boxed warning to the drug label, its most serious type of warning.
Read More…
More on Health News
Post a Comment